These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Parry D; Mahony D; Wills K; Lees E Mol Cell Biol; 1999 Mar; 19(3):1775-83. PubMed ID: 10022865 [TBL] [Abstract][Full Text] [Related]
3. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Reynisdóttir I; Polyak K; Iavarone A; Massagué J Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471 [TBL] [Abstract][Full Text] [Related]
4. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells. Said TK; Medina D Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257 [TBL] [Abstract][Full Text] [Related]
5. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb. Ezhevsky SA; Nagahara H; Vocero-Akbani AM; Gius DR; Wei MC; Dowdy SF Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10699-704. PubMed ID: 9380698 [TBL] [Abstract][Full Text] [Related]
6. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Hirai H; Roussel MF; Kato JY; Ashmun RA; Sherr CJ Mol Cell Biol; 1995 May; 15(5):2672-81. PubMed ID: 7739547 [TBL] [Abstract][Full Text] [Related]
7. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6. Noh SJ; Li Y; Xiong Y; Guan KL Cancer Res; 1999 Feb; 59(3):558-64. PubMed ID: 9973200 [TBL] [Abstract][Full Text] [Related]
8. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase. Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508 [TBL] [Abstract][Full Text] [Related]
9. Involvement of the Ink4 proteins p16 and p15 in T-lymphocyte senescence. Erickson S; Sangfelt O; Heyman M; Castro J; Einhorn S; Grandér D Oncogene; 1998 Aug; 17(5):595-602. PubMed ID: 9704925 [TBL] [Abstract][Full Text] [Related]
10. Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors. Thullberg M; Bartkova J; Khan S; Hansen K; Rönnstrand L; Lukas J; Strauss M; Bartek J FEBS Lett; 2000 Mar; 470(2):161-6. PubMed ID: 10734227 [TBL] [Abstract][Full Text] [Related]
11. Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b). Malumbres M; Pérez De Castro I; Hernández MI; Jiménez M; Corral T; Pellicer A Mol Cell Biol; 2000 Apr; 20(8):2915-25. PubMed ID: 10733595 [TBL] [Abstract][Full Text] [Related]
13. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Guan KL; Jenkins CW; Li Y; Nichols MA; Wu X; O'Keefe CL; Matera AG; Xiong Y Genes Dev; 1994 Dec; 8(24):2939-52. PubMed ID: 8001816 [TBL] [Abstract][Full Text] [Related]
14. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Alcorta DA; Xiong Y; Phelps D; Hannon G; Beach D; Barrett JC Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13742-7. PubMed ID: 8943005 [TBL] [Abstract][Full Text] [Related]
15. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma. Easton J; Wei T; Lahti JM; Kidd VJ Cancer Res; 1998 Jun; 58(12):2624-32. PubMed ID: 9635589 [TBL] [Abstract][Full Text] [Related]
16. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes. McConnell BB; Gregory FJ; Stott FJ; Hara E; Peters G Mol Cell Biol; 1999 Mar; 19(3):1981-9. PubMed ID: 10022885 [TBL] [Abstract][Full Text] [Related]